Pharmaceutical dealmaking has emerged as a rare area of collaboration between China and the West amid rising geopolitical tensions. This year, seven major pharma companies have invested over $3.15 billion in licensing or acquiring new drug molecules from China, while others are enhancing their local presence to uncover valuable opportunities.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
